JP2017523201A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523201A5
JP2017523201A5 JP2017505456A JP2017505456A JP2017523201A5 JP 2017523201 A5 JP2017523201 A5 JP 2017523201A5 JP 2017505456 A JP2017505456 A JP 2017505456A JP 2017505456 A JP2017505456 A JP 2017505456A JP 2017523201 A5 JP2017523201 A5 JP 2017523201A5
Authority
JP
Japan
Prior art keywords
alkyl
disorders
disorder
compound
monohalo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017505456A
Other languages
English (en)
Japanese (ja)
Other versions
JP6615864B2 (ja
JP2017523201A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/067533 external-priority patent/WO2016016381A1/en
Publication of JP2017523201A publication Critical patent/JP2017523201A/ja
Publication of JP2017523201A5 publication Critical patent/JP2017523201A5/ja
Application granted granted Critical
Publication of JP6615864B2 publication Critical patent/JP6615864B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017505456A 2014-08-01 2015-07-30 6,7−ジヒドロピラゾロ[1,5−a]ピラジン−4(5H)−オン化合物およびMGLUR2受容体の負のアロステリック調節因子としてのそれらの使用 Expired - Fee Related JP6615864B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14179599 2014-08-01
EP14179599.7 2014-08-01
PCT/EP2015/067533 WO2016016381A1 (en) 2014-08-01 2015-07-30 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors

Publications (3)

Publication Number Publication Date
JP2017523201A JP2017523201A (ja) 2017-08-17
JP2017523201A5 true JP2017523201A5 (enExample) 2018-09-06
JP6615864B2 JP6615864B2 (ja) 2019-12-04

Family

ID=51257438

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017505456A Expired - Fee Related JP6615864B2 (ja) 2014-08-01 2015-07-30 6,7−ジヒドロピラゾロ[1,5−a]ピラジン−4(5H)−オン化合物およびMGLUR2受容体の負のアロステリック調節因子としてのそれらの使用

Country Status (15)

Country Link
US (1) US10112949B2 (enExample)
EP (1) EP3174880B1 (enExample)
JP (1) JP6615864B2 (enExample)
KR (1) KR102531693B1 (enExample)
CN (1) CN106573935B (enExample)
AR (1) AR101393A1 (enExample)
AU (1) AU2015295299B2 (enExample)
BR (1) BR112017001998A2 (enExample)
CA (1) CA2954218C (enExample)
EA (1) EA031038B1 (enExample)
ES (1) ES2702192T3 (enExample)
JO (1) JO3601B1 (enExample)
MX (1) MX2017001453A (enExample)
TW (1) TWI696625B (enExample)
WO (1) WO2016016381A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20150177B1 (ar) 2014-08-01 2021-08-17 Janssen Pharmaceutica Nv مركبات 6 ، 7 ثاني هيدرو بيرازولو [ 1، 5 الفا ] بيرازين – 4 (5 يد) – اون واستخدامها كمنظمات الوسترية سلبية لمستقبلات ملجور 2
JOP20150179B1 (ar) 2014-08-01 2021-08-17 Janssen Pharmaceutica Nv مركبات 6 ، 7 ثاني هيدرو بيرازولو [ 1، 5 الفا ] بيرازين – 4 (5 يد) – اون واستخدامها كمنظمات الوسترية سلبية لمستقبلات ملجور 2
JP6861154B2 (ja) 2014-12-03 2021-04-21 ヤンセン ファーマシューティカ エヌ.ベー. 放射標識されたmGluR2 PETリガンド
JP6689856B2 (ja) * 2014-12-03 2020-04-28 ヤンセン ファーマシューティカ エヌ.ベー. 6,7−ジヒドロピラゾロ[1,5−a]ピラジン−4(5H)−オン化合物およびMGLUR2受容体の負のアロステリック調節因子としてのそれらの使用
CA3003998A1 (en) * 2015-12-18 2017-06-22 Janssen Pharmaceutica Nv Radiolabelled mglur2/3 pet ligands
US11045562B2 (en) 2015-12-18 2021-06-29 Janssen Pharmaceutica Nv Radiolabelled mGluR2/3 PET ligands
MY201041A (en) 2017-11-24 2024-01-31 Sumitomo Pharma Co Ltd Substituted pyrazolo[1,5-a]pyrazines as negative allosteric modulators of group ii metabotropic glutamate receptor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004054665A1 (de) * 2004-11-12 2006-05-18 Bayer Cropscience Gmbh Substituierte bi- und tricyclische Pyrazol-Derivate Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
ATE460417T1 (de) * 2005-03-23 2010-03-15 Hoffmann La Roche Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten
ES2440001T3 (es) 2009-05-12 2014-01-27 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-A]piridina y su uso para el tratamiento o prevención de trastornos neurológicos y psiquiátricos
JP2013545822A (ja) * 2010-12-17 2013-12-26 ヴァンダービルト ユニバーシティー mGluR5受容体のアロステリック調節剤としての、二環式トリアゾールラクタムおよびピラゾールラクタム
WO2012172093A1 (en) * 2011-06-17 2012-12-20 Merz Pharma Gmbh & Co. Kgaa Dihydroindolizine derivate as metabotropic glutamate receptor modulators
AU2012332895B2 (en) 2011-11-03 2015-12-17 Merck Sharp & Dohme Corp. Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
EP2666775A1 (en) 2012-05-21 2013-11-27 Domain Therapeutics Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors
WO2013192350A1 (en) * 2012-06-20 2013-12-27 Vanderbilt University Substituted bicyclic aralkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptors
BR112014031896A2 (pt) * 2012-06-20 2017-06-27 Univ Vanderbilt composto, composição farmacêutica, e, método para o tratamento de um distúrbio
US20130345204A1 (en) * 2012-06-20 2013-12-26 Vanderbilt University Substituted bicyclic cycloalkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptors
KR20150070187A (ko) 2012-10-23 2015-06-24 에프. 호프만-라 로슈 아게 자폐 장애의 치료를 위한 mglu2/3 길항제
RU2708391C2 (ru) * 2014-08-01 2019-12-06 Янссен Фармацевтика Нв 6,7-дигидропиразоло[1,5-а]пиразин-4(5h)-оновые соединения и их применение в качестве отрицательных аллостерических модуляторов рецепторов mglur2

Similar Documents

Publication Publication Date Title
JP2017523201A5 (enExample)
JP2017522340A5 (enExample)
JP2017523202A5 (enExample)
JP2017526659A5 (enExample)
JP2017528515A5 (enExample)
CN107438593B (zh) 治疗化合物及其用途
CY1125460T1 (el) Ενωσεις ιμιδαζο [4,5-d]πυρρολο [2,3-β]πυριδινης ως αναστολεις κινασων janus
CN112409363B (zh) 用于治疗认知损害的苯并二氮杂䓬衍生物、组合物和方法
AU2014272695B2 (en) Pyrazolo-pyrrolidin-4-one derivatives as BET inhibitors and their use in the treatment of disease
PH12019501355A1 (en) Small molecule inhibitors of the jak family of kinases
JP6268183B2 (ja) Pi3キナーゼモジュレータとしてのヘテロ芳香族化合物、及びその使用方法
RU2017106489A (ru) 6,7-дигидропиразоло[1,5-а]пиразин-4(5h)-оновые соединения и их применение в качестве отрицательных аллостерических модуляторов рецепторов mglur2
AR087336A1 (es) Compuestos de 2-(2,4,5-anilino sustituido)pirimidina
JP2018510851A (ja) 治療用ピリダジン化合物およびその使用
WO2013155506A1 (en) Novel compositions and methods
RU2017106100A (ru) 6,7-ДИГИДРОПИРАЗОЛО[1,5-α]ПИРАЗИН-4(5Н)-ОНОВЫЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ОТРИЦАТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ MGLUR2
CA2898294C (en) Heteroaromatic compounds as pi3 kinase modulators
JP6814730B2 (ja) 治療用化合物およびその使用
JP2021528427A (ja) 認知障害を処置するためのベンゾジアゼピン誘導体、組成物および方法
EP3189049A1 (en) Phthalazine derivatives of formula (i) as pcaf and gcn5 inhibitors for use in the treatment of cancer
WO2018130869A1 (en) Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
RU2017123038A (ru) 6,7-ДИГИДРОПИРАЗОЛО[1,5-a]ПИРАЗИН-4(5H)-ОНОВЫЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ОТРИЦАТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ MGLUR2
JP2017536399A5 (enExample)
JP2018507191A (ja) 治療用化合物およびその使用
JP2018534314A5 (enExample)